Skip to content
DataLookout
Menu

PASSNCT07741591

Impact of Perioperative Antibiotic Use on Surgical Scarring

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 9 words Show 6 more changesShow less
    • Completed without a posted recruiting period
    • Final enrollment: 2744 participants (planned 5000)
    • Primary completion date changed from estimate of Aug 15, 2026 to Oct 15, 2026
    • Study completion date changed from estimate of Aug 15, 2026 to Nov 5, 2026
    • Secondary endpoints: details revised at 3 of 4 entries
    • Site contact updated
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Overall Scar Appearance Score Assessed Using a Modified Visual Analogue Scale
Timeframe: Scar photographs were taken during postoperative clinical follow-up, with an overall range from 3 months to 20 years after surgery. Given the wide span, the assessments will be stratified and reported according to the actual time of photography, for exam

Secondary (4)

Scar Color Score Assessed Using a Modified Visual Analogue Scale
Scar Texture Score Assessed Using a Modified Visual Analogue Scale
Scar Width
Scar-Related Complications

Arms and interventions

Retrospective Surgical Scar Cohort

Adult patients who underwent body surface surgery at Nanfang Hospital between January 1, 2005 and January 1, 2025 and have available surgical records, perioperative medication records, and scar outcome information.

Other: Perioperative Antibiotic Exposure

Sites

1 site in 1 country

  • Nanfang Hospital, Southern Medical UniversityGuangzhou, Guangdong, China